Weekly Dose: Keytruda may be a miracle cancer drug, but can those who need it afford it?
Nicholas Huntington, Walter and Eliza Hall Institute Keytruda (generic name pembrolizumab) is an immunotherapy drug…
Browsing: Keytruda
30 year treatment drought breaks for most common form of bladder cancer
The Therapeutic Goods Administration has approved pembrolizumab (KEYTRUDA 200mg, every three weeks) as monotherapy for…
We don’t need to change how we subsidise ‘breakthrough’ cancer treatments
Richard De Abreu Lourenco, University of Technology Sydney; Marion Haas, University of Technology Sydney, and…
Combination of ground-breaking treatments offer powerful new path for blood cancer therapies
Researchers have identified for the first time how a new class of epigenetic drug engages with…
‘Revolutionary’ melanoma drug worth $150,000 a year listed on PBS
The ABC. Patients with advanced skin cancer will soon have affordable access to a promising…